Stripe, Anthropic and OpenAI are backing an effort to stop respiratory infections
TL;DR
Stripe, Anthropic, the OpenAI Foundation, Flu Lab, Bill Gates and other backers are launching Intercept, a new effort aimed at respiratory infections. The roughly $500 million initiative will fund early work on broad vaccines, sprays, pills and air-cleaning tools for colds, flu, Covid and other airborne pathogens. Intercept also wants a buyer network including JPMorgan Chase, Mastercard, Meta, Stripe and Anthropic. Experts welcome the funding, but warn the goal may be bigger than the budget.
Nauti's Take
This has a clear rescue-the-world PR smell, but the core problem is real: indoor air is still poorly managed infrastructure. If the money only funds promising papers, it will fade quickly.
If Intercept can connect buyers, building standards and clinically credible products, pandemic lessons could turn into everyday protection. The hard caveat: $500 million is a lot for a campaign, but not much for multiple virus families, drug development and global air-cleaning adoption at the same time.
Briefingshow
Respiratory infections are not just an annual nuisance. They cost businesses billions, strain health systems and Covid showed how quickly airborne viruses can shut down work, schools and care. The notable part is the mix of biotech funding and demand-building: Intercept wants to finance early science and create first customers for prevention tools.
Sources